Evidence map›Paper›PMID 34206444›Full record

ArticleInternational journal of molecular sciences2021

Lipidation of Temporin-1CEb Derivatives as a Tool for Activity Improvement, Pros and Cons of the Approach.

Paulina Kosikowska-Adamus, Emilia Sikorska, Dariusz Wyrzykowski, Aleksandra Walewska, Anna Golda, Milena Deptuła, Michał Obuchowski, Adam Prahl, Michał Pikuła, Adam Lesner

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Membrane-Peptide Interactions: From Basics to Current Applications 2.0.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Paulina Kosikowska-AdamusFaculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.ORCID 0000-0002-4737-2771
Emilia SikorskaFaculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.
Dariusz WyrzykowskiFaculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.
Aleksandra WalewskaFaculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.
Anna GoldaDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Kraków, Poland.ORCID 0000-0002-3813-4966
Milena DeptułaLaboratory of Tissue Engineering and Regenerative Medicine, Department of Embryology, Medical University of Gdansk, 80-210 Gdańsk, Poland.ORCID 0000-0003-4875-770X
Michał ObuchowskiDepartment of Medical Biotechnology, Intercollegiate Faculty of Biotechnology UG-MUG, Medical University of Gdansk, 80-210 Gdańsk, Poland.
Adam PrahlFaculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.
Michał PikułaLaboratory of Tissue Engineering and Regenerative Medicine, Department of Embryology, Medical University of Gdansk, 80-210 Gdańsk, Poland.ORCID 0000-0001-7751-9781
Adam LesnerFaculty of Chemistry, University of Gdansk, 80-309 Gdańsk, Poland.ORCID 0000-0001-8335-3431
University of Gdańsk · PLGdańsk Medical University · PLJagiellonian University · PL

Funding

Polish National Science Center 2012/04/S/ST5/00074;2016/23/D/ST5/02234
6 · The paper itself

Abstract

The alarming raise of multi-drug resistance among human microbial pathogens makes the development of novel therapeutics a priority task. In contrast to conventional antibiotics, antimicrobial peptides (AMPs), besides evoking a broad spectrum of activity against microorganisms, could offer additional benefits, such as the ability to neutralize toxins, modulate inflammatory response, eradicate bacterial and fungal biofilms or prevent their development. The latter properties are of special interest, as most antibiotics available on the market have limited ability to diffuse through rigid structures of biofilms. Lipidation of AMPs is considered as an effective approach for enhancement of their antimicrobial potential and in vivo stability; however, it could also have undesired impact on selectivity, solubility or the aggregation state of the modified peptides. In the present work, we describe the results of structural modifications of compounds designed based on cationic antimicrobial peptides DK5 and CAR-PEG-DK5, derivatized at their N-terminal part with fatty acids with different lengths of carbon chain. The proposed modifications substantially improved antimicrobial properties of the final compounds and their effectiveness in inhibition of biofilm development as well as eradication of pre-formed 24 h old biofilms of

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesBacteriaDrug Resistance, MicrobialDrug StabilityHumansMicrobial Sensitivity TestsMolecular StructureSpectrum AnalysisStructure-Activity RelationshipThermodynamicsAnti-Infective AgentsAntimicrobial Cationic PeptidestemporinAMP activity improvementantimicrobial peptideslipidation of peptidesmembranolytic properties of peptidesmode of action of lipopeptides

Identifiers

PMID34206444
PMCPMC8269107
OpenAlexW3175890021

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.